LUNG CANCER STAGE III
Clinical trials for LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple threat: new combo aims to stop lung cancer in its tracks
Disease control OngoingThis phase II trial tests a three-step approach for stage II or III non-small cell lung cancer. First, the main tumor gets a high-dose radiation blast (SBRT). Then, the chest lymph nodes receive standard radiation plus chemotherapy. Finally, patients get an immunotherapy drug (du…
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Lung cancer Treatment's hidden heart risk under the microscope
Knowledge-focused OngoingThis study tracks 221 people with stage II or III lung cancer to see how chemoradiation therapy affects their heart health. Participants undergo heart scans, blood tests, and quality-of-life surveys before, during, and for at least two years after treatment. The goal is to better…
Matched conditions: LUNG CANCER STAGE III
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC